

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of vitamin D biosynthetic process (GO:0060556) | 5.63438290 |
| 2 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.50525445 |
| 3 | modulation by symbiont of host immune response (GO:0052553) | 5.50525445 |
| 4 | positive regulation by symbiont of host defense response (GO:0052509) | 5.50525445 |
| 5 | modulation by symbiont of host defense response (GO:0052031) | 5.50525445 |
| 6 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.50525445 |
| 7 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.50525445 |
| 8 | response to peptidoglycan (GO:0032494) | 4.71190511 |
| 9 | response to muramyl dipeptide (GO:0032495) | 4.64449666 |
| 10 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.60534036 |
| 11 | NIK/NF-kappaB signaling (GO:0038061) | 4.56349402 |
| 12 | regulation of cytokine secretion involved in immune response (GO:0002739) | 4.55506470 |
| 13 | regulation of vitamin metabolic process (GO:0030656) | 4.47083828 |
| 14 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.37827771 |
| 15 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.37827771 |
| 16 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.32043950 |
| 17 | positive regulation of interferon-alpha production (GO:0032727) | 4.29167030 |
| 18 | regulation of interferon-alpha production (GO:0032647) | 4.15303175 |
| 19 | neutrophil activation involved in immune response (GO:0002283) | 4.10663383 |
| 20 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.06865433 |
| 21 | macrophage activation involved in immune response (GO:0002281) | 3.98900412 |
| 22 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.95917933 |
| 23 | regulation of mononuclear cell migration (GO:0071675) | 3.89125285 |
| 24 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.86071654 |
| 25 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.86016694 |
| 26 | immunoglobulin mediated immune response (GO:0016064) | 3.85701576 |
| 27 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.80563730 |
| 28 | type I interferon signaling pathway (GO:0060337) | 3.78119152 |
| 29 | cellular response to type I interferon (GO:0071357) | 3.78119152 |
| 30 | response to type I interferon (GO:0034340) | 3.78035295 |
| 31 | positive regulation of antigen processing and presentation (GO:0002579) | 3.77220338 |
| 32 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 3.73405452 |
| 33 | response to host immune response (GO:0052572) | 3.72519119 |
| 34 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.72519119 |
| 35 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.67909290 |
| 36 | myeloid dendritic cell differentiation (GO:0043011) | 3.66357228 |
| 37 | positive regulation of interleukin-12 production (GO:0032735) | 3.64832780 |
| 38 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 3.63603337 |
| 39 | response to protozoan (GO:0001562) | 3.62979141 |
| 40 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.60328500 |
| 41 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.60186932 |
| 42 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.56645419 |
| 43 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.56642686 |
| 44 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.52739530 |
| 45 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.51008101 |
| 46 | positive regulation of interferon-beta production (GO:0032728) | 3.41526059 |
| 47 | response to host defenses (GO:0052200) | 3.39158869 |
| 48 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.39158869 |
| 49 | response to host (GO:0075136) | 3.39158869 |
| 50 | microglial cell activation (GO:0001774) | 3.35735639 |
| 51 | regulation of immunoglobulin secretion (GO:0051023) | 3.35156408 |
| 52 | germinal center formation (GO:0002467) | 3.33800989 |
| 53 | activation of MAPKKK activity (GO:0000185) | 3.32198039 |
| 54 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.32175537 |
| 55 | myeloid dendritic cell activation (GO:0001773) | 3.30999034 |
| 56 | regulation of heat generation (GO:0031650) | 3.30487137 |
| 57 | natural killer cell mediated immunity (GO:0002228) | 3.29945322 |
| 58 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.29945322 |
| 59 | * interferon-gamma-mediated signaling pathway (GO:0060333) | 3.28370759 |
| 60 | glycosphingolipid catabolic process (GO:0046479) | 3.25221871 |
| 61 | T-helper 1 type immune response (GO:0042088) | 3.25095512 |
| 62 | positive regulation of heat generation (GO:0031652) | 3.23328743 |
| 63 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.23086494 |
| 64 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.21039594 |
| 65 | oligosaccharide catabolic process (GO:0009313) | 3.20983192 |
| 66 | granulocyte activation (GO:0036230) | 3.17920537 |
| 67 | regulation of antigen processing and presentation (GO:0002577) | 3.17131163 |
| 68 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.16375438 |
| 69 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.15319031 |
| 70 | positive regulation of humoral immune response (GO:0002922) | 3.14241499 |
| 71 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.14169100 |
| 72 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.13631713 |
| 73 | response to interferon-alpha (GO:0035455) | 3.13358214 |
| 74 | detection of molecule of bacterial origin (GO:0032490) | 3.11494723 |
| 75 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.10566630 |
| 76 | * cellular response to lipopolysaccharide (GO:0071222) | 3.10074029 |
| 77 | neutrophil activation (GO:0042119) | 3.08463536 |
| 78 | regulation of interleukin-12 production (GO:0032655) | 3.07623712 |
| 79 | positive regulation of acute inflammatory response (GO:0002675) | 3.07618242 |
| 80 | negative regulation of interleukin-12 production (GO:0032695) | 3.04235084 |
| 81 | regulation of fever generation (GO:0031620) | 3.02637958 |
| 82 | cellular response to virus (GO:0098586) | 3.00719064 |
| 83 | I-kappaB phosphorylation (GO:0007252) | 2.99242651 |
| 84 | * cellular response to molecule of bacterial origin (GO:0071219) | 2.99238729 |
| 85 | regulation of podosome assembly (GO:0071801) | 2.98993934 |
| 86 | positive regulation of interleukin-6 production (GO:0032755) | 2.98988999 |
| 87 | * regulation of nitric oxide biosynthetic process (GO:0045428) | 2.97302334 |
| 88 | B cell mediated immunity (GO:0019724) | 2.96828287 |
| 89 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.96411315 |
| 90 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.94810181 |
| 91 | negative regulation of interleukin-17 production (GO:0032700) | 2.93969383 |
| 92 | dendritic cell differentiation (GO:0097028) | 2.92905028 |
| 93 | negative regulation of lipid storage (GO:0010888) | 2.92720684 |
| 94 | response to interferon-beta (GO:0035456) | 2.92037794 |
| 95 | macrophage activation (GO:0042116) | 2.91049361 |
| 96 | negative regulation of viral genome replication (GO:0045071) | 2.90010475 |
| 97 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.89887627 |
| 98 | negative regulation of production of molecular mediator of immune response (GO:0002701) | 2.89885894 |
| 99 | cellular response to interferon-beta (GO:0035458) | 2.89821561 |
| 100 | glycolipid catabolic process (GO:0019377) | 2.89420436 |
| 101 | regulation of NF-kappaB import into nucleus (GO:0042345) | 2.88527965 |
| 102 | modulation by symbiont of host cellular process (GO:0044068) | 2.87948855 |
| 103 | cytokine secretion (GO:0050663) | 2.87875061 |
| 104 | regulation of chemokine biosynthetic process (GO:0045073) | 2.87862304 |
| 105 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 2.87278725 |
| 106 | regulation of type 2 immune response (GO:0002828) | 2.86569583 |
| 107 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.86340305 |
| 108 | regulation of T-helper cell differentiation (GO:0045622) | 2.85172896 |
| 109 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.84813536 |
| 110 | regulation of gamma-delta T cell activation (GO:0046643) | 2.84134239 |
| 111 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.82135065 |
| 112 | positive regulation of type 2 immune response (GO:0002830) | 2.82103187 |
| 113 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.81896178 |
| 114 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 2.79330843 |
| 115 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.79306057 |
| 116 | regulation of integrin activation (GO:0033623) | 2.79283620 |
| 117 | myeloid cell activation involved in immune response (GO:0002275) | 2.79064793 |
| 118 | defense response to protozoan (GO:0042832) | 2.78671106 |
| 119 | positive regulation of macrophage cytokine production (GO:0060907) | 2.77038242 |
| 120 | regulation of cholesterol storage (GO:0010885) | 2.76728762 |
| 121 | respiratory burst (GO:0045730) | 2.76132213 |
| 122 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 2.75796709 |
| 123 | * cellular response to interferon-gamma (GO:0071346) | 2.75365963 |
| 124 | * positive regulation of nitric oxide biosynthetic process (GO:0045429) | 2.74784370 |
| 125 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.72047657 |
| 126 | wound healing, spreading of epidermal cells (GO:0035313) | 2.72024201 |
| 127 | regulation of chronic inflammatory response (GO:0002676) | 2.71829623 |
| 128 | negative regulation of growth of symbiont in host (GO:0044130) | 2.71775012 |
| 129 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.71775012 |
| 130 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.71775012 |
| 131 | regulation of growth of symbiont in host (GO:0044126) | 2.71775012 |
| 132 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.71160921 |
| 133 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.70925566 |
| 134 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.70353401 |
| 135 | positive regulation of p38MAPK cascade (GO:1900745) | 2.70273533 |
| 136 | low-density lipoprotein particle clearance (GO:0034383) | 2.69788018 |
| 137 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.69785327 |
| 138 | leukocyte mediated cytotoxicity (GO:0001909) | 2.69731148 |
| 139 | cellular response to nicotine (GO:0071316) | 2.69488949 |
| 140 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.68263221 |
| 141 | regulation of interleukin-17 production (GO:0032660) | 2.68139388 |
| 142 | monocyte chemotaxis (GO:0002548) | 2.67341201 |
| 143 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.65435867 |
| 144 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.64638193 |
| 145 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.64617156 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.16834844 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.82896543 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.61272517 |
| 4 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.10711183 |
| 5 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.84495213 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.74256329 |
| 7 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.68931827 |
| 8 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.67726608 |
| 9 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.56035172 |
| 10 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.51794486 |
| 11 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.49916064 |
| 12 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.45282002 |
| 13 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.13271511 |
| 14 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.13106309 |
| 15 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.97530067 |
| 16 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.91018422 |
| 17 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.73500638 |
| 18 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.71287494 |
| 19 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.65150158 |
| 20 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.40102953 |
| 21 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.16251904 |
| 22 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.06973661 |
| 23 | GATA1_22025678_ChIP-Seq_K562_Human | 2.02290123 |
| 24 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.98083300 |
| 25 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.89818859 |
| 26 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.88100964 |
| 27 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.84008021 |
| 28 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.80031212 |
| 29 | MAF_26560356_Chip-Seq_TH1_Human | 1.73510388 |
| 30 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.69587098 |
| 31 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.66047854 |
| 32 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.64035899 |
| 33 | MYB_26560356_Chip-Seq_TH2_Human | 1.64001783 |
| 34 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.60800684 |
| 35 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.59448388 |
| 36 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.56738068 |
| 37 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.51585287 |
| 38 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.51059912 |
| 39 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.50612809 |
| 40 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.43012129 |
| 41 | MYB_26560356_Chip-Seq_TH1_Human | 1.42660368 |
| 42 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.41592353 |
| 43 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.41160875 |
| 44 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.40223639 |
| 45 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.39073211 |
| 46 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.38674723 |
| 47 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.37515416 |
| 48 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.36282398 |
| 49 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.32857454 |
| 50 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.31965953 |
| 51 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.31071232 |
| 52 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.30131870 |
| 53 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.29482089 |
| 54 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.27222510 |
| 55 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.27009729 |
| 56 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.25347886 |
| 57 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.24331740 |
| 58 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.24331740 |
| 59 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.23460289 |
| 60 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.21619791 |
| 61 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19355948 |
| 62 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.18784257 |
| 63 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.17931491 |
| 64 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.17127153 |
| 65 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.16378823 |
| 66 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.15975245 |
| 67 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.14303504 |
| 68 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.10781627 |
| 69 | UTX_26944678_Chip-Seq_JUKART_Human | 1.08743199 |
| 70 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.08671971 |
| 71 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.06567004 |
| 72 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.06337118 |
| 73 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.05980942 |
| 74 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.03533101 |
| 75 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.01096737 |
| 76 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.00732806 |
| 77 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.00732806 |
| 78 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.00732806 |
| 79 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.99580230 |
| 80 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.99002109 |
| 81 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.98755227 |
| 82 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.97650456 |
| 83 | GATA3_26560356_Chip-Seq_TH2_Human | 0.97110075 |
| 84 | * MYC_22102868_ChIP-Seq_BL_Human | 0.96576454 |
| 85 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96427017 |
| 86 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.95118741 |
| 87 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.93831584 |
| 88 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.93512596 |
| 89 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.93131859 |
| 90 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.93011711 |
| 91 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.92430077 |
| 92 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.92213892 |
| 93 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.91704833 |
| 94 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.90108493 |
| 95 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.89241297 |
| 96 | * SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.87794630 |
| 97 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.87666602 |
| 98 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.87094339 |
| 99 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.86976216 |
| 100 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.86622295 |
| 101 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.86489046 |
| 102 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.86315260 |
| 103 | KDM2B_26808549_Chip-Seq_K562_Human | 0.85911309 |
| 104 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.85866684 |
| 105 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.85670320 |
| 106 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.85570898 |
| 107 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.85309907 |
| 108 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.85268357 |
| 109 | MAF_26560356_Chip-Seq_TH2_Human | 0.84330757 |
| 110 | GATA1_19941826_ChIP-Seq_K562_Human | 0.84308339 |
| 111 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.84203095 |
| 112 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.82346081 |
| 113 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.82205180 |
| 114 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.82043581 |
| 115 | CJUN_26792858_Chip-Seq_BT549_Human | 0.82031598 |
| 116 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.81042843 |
| 117 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.80742869 |
| 118 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.79997713 |
| 119 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.79243785 |
| 120 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.78800427 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.03895119 |
| 2 | MP0003724_increased_susceptibility_to | 3.39041850 |
| 3 | MP0003436_decreased_susceptibility_to | 3.38807427 |
| 4 | MP0003303_peritoneal_inflammation | 3.37147320 |
| 5 | * MP0009785_altered_susceptibility_to | 3.29402390 |
| 6 | MP0000685_abnormal_immune_system | 3.16965351 |
| 7 | MP0002254_reproductive_system_inflammat | 2.83416600 |
| 8 | MP0004510_myositis | 2.83290262 |
| 9 | * MP0002148_abnormal_hypersensitivity_rea | 2.83210715 |
| 10 | * MP0005000_abnormal_immune_tolerance | 2.72985326 |
| 11 | * MP0005387_immune_system_phenotype | 2.68620083 |
| 12 | * MP0001790_abnormal_immune_system | 2.68620083 |
| 13 | MP0002419_abnormal_innate_immunity | 2.65949127 |
| 14 | * MP0005025_abnormal_response_to | 2.60172364 |
| 15 | MP0006082_CNS_inflammation | 2.59371216 |
| 16 | MP0002139_abnormal_hepatobiliary_system | 2.53252770 |
| 17 | MP0005671_abnormal_response_to | 2.46835995 |
| 18 | MP0001800_abnormal_humoral_immune | 2.41035192 |
| 19 | MP0002452_abnormal_antigen_presenting | 2.39064776 |
| 20 | MP0005451_abnormal_body_composition | 2.33009172 |
| 21 | MP0002723_abnormal_immune_serum | 2.29972303 |
| 22 | MP0009278_abnormal_bone_marrow | 2.24599803 |
| 23 | MP0002138_abnormal_hepatobiliary_system | 2.16185484 |
| 24 | MP0004947_skin_inflammation | 2.14899559 |
| 25 | MP0001819_abnormal_immune_cell | 2.01617653 |
| 26 | MP0002420_abnormal_adaptive_immunity | 1.98618056 |
| 27 | MP0005167_abnormal_blood-brain_barrier | 1.96306362 |
| 28 | MP0002405_respiratory_system_inflammati | 1.93154880 |
| 29 | MP0001533_abnormal_skeleton_physiology | 1.90824859 |
| 30 | MP0004782_abnormal_surfactant_physiolog | 1.89600466 |
| 31 | MP0006054_spinal_hemorrhage | 1.88675562 |
| 32 | * MP0003448_altered_tumor_morphology | 1.82390821 |
| 33 | MP0001853_heart_inflammation | 1.82097988 |
| 34 | MP0003300_gastrointestinal_ulcer | 1.79391660 |
| 35 | MP0009764_decreased_sensitivity_to | 1.77905324 |
| 36 | MP0005397_hematopoietic_system_phenotyp | 1.77182676 |
| 37 | MP0001545_abnormal_hematopoietic_system | 1.77182676 |
| 38 | MP0005058_abnormal_lysosome_morphology | 1.75535120 |
| 39 | MP0005464_abnormal_platelet_physiology | 1.71226384 |
| 40 | * MP0010155_abnormal_intestine_physiology | 1.69809212 |
| 41 | MP0000343_altered_response_to | 1.69568771 |
| 42 | * MP0001845_abnormal_inflammatory_respons | 1.67982516 |
| 43 | MP0002006_tumorigenesis | 1.55972876 |
| 44 | MP0008469_abnormal_protein_level | 1.48958775 |
| 45 | MP0002166_altered_tumor_susceptibility | 1.48865500 |
| 46 | MP0003828_pulmonary_edema | 1.47672339 |
| 47 | * MP0000716_abnormal_immune_system | 1.46224427 |
| 48 | MP0005310_abnormal_salivary_gland | 1.44532601 |
| 49 | MP0001851_eye_inflammation | 1.43688986 |
| 50 | MP0003566_abnormal_cell_adhesion | 1.40613082 |
| 51 | MP0001958_emphysema | 1.38879393 |
| 52 | * MP0002398_abnormal_bone_marrow | 1.38272159 |
| 53 | MP0003075_altered_response_to | 1.37618480 |
| 54 | MP0001879_abnormal_lymphatic_vessel | 1.35333904 |
| 55 | MP0003172_abnormal_lysosome_physiology | 1.35178962 |
| 56 | MP0003195_calcinosis | 1.35149602 |
| 57 | MP0003690_abnormal_glial_cell | 1.34877881 |
| 58 | MP0003806_abnormal_nucleotide_metabolis | 1.33087980 |
| 59 | MP0000858_altered_metastatic_potential | 1.32814628 |
| 60 | MP0005076_abnormal_cell_differentiation | 1.30028085 |
| 61 | MP0009333_abnormal_splenocyte_physiolog | 1.28145590 |
| 62 | MP0003191_abnormal_cellular_cholesterol | 1.27694069 |
| 63 | MP0003656_abnormal_erythrocyte_physiolo | 1.21280296 |
| 64 | MP0002277_abnormal_respiratory_mucosa | 1.21275443 |
| 65 | MP0009840_abnormal_foam_cell | 1.21122212 |
| 66 | MP0001873_stomach_inflammation | 1.20475533 |
| 67 | MP0002998_abnormal_bone_remodeling | 1.19990988 |
| 68 | MP0010352_gastrointestinal_tract_polyps | 1.18774061 |
| 69 | MP0005164_abnormal_response_to | 1.18655841 |
| 70 | MP0000689_abnormal_spleen_morphology | 1.18033689 |
| 71 | * MP0002429_abnormal_blood_cell | 1.17420747 |
| 72 | MP0001542_abnormal_bone_strength | 1.17342240 |
| 73 | MP0010307_abnormal_tumor_latency | 1.11973695 |
| 74 | MP0002722_abnormal_immune_system | 1.11143092 |
| 75 | MP0000604_amyloidosis | 1.08655963 |
| 76 | * MP0003453_abnormal_keratinocyte_physiol | 1.08412658 |
| 77 | MP0000569_abnormal_digit_pigmentation | 1.07209053 |
| 78 | MP0005165_increased_susceptibility_to | 1.05484173 |
| 79 | MP0000767_abnormal_smooth_muscle | 1.05144805 |
| 80 | MP0003763_abnormal_thymus_physiology | 1.05031714 |
| 81 | * MP0003091_abnormal_cell_migration | 1.04502927 |
| 82 | MP0005166_decreased_susceptibility_to | 1.01487692 |
| 83 | MP0010368_abnormal_lymphatic_system | 0.97761608 |
| 84 | * MP0000249_abnormal_blood_vessel | 0.97037483 |
| 85 | MP0005390_skeleton_phenotype | 0.96751045 |
| 86 | MP0009763_increased_sensitivity_to | 0.94778732 |
| 87 | MP0004808_abnormal_hematopoietic_stem | 0.92287342 |
| 88 | MP0002877_abnormal_melanocyte_morpholog | 0.87352409 |
| 89 | MP0000920_abnormal_myelination | 0.86809335 |
| 90 | MP0003705_abnormal_hypodermis_morpholog | 0.85248126 |
| 91 | * MP0005023_abnormal_wound_healing | 0.84305928 |
| 92 | MP0004883_abnormal_blood_vessel | 0.84165532 |
| 93 | MP0003950_abnormal_plasma_membrane | 0.82024775 |
| 94 | MP0009765_abnormal_xenobiotic_induced | 0.81913401 |
| 95 | MP0003329_amyloid_beta_deposits | 0.79819364 |
| 96 | MP0001663_abnormal_digestive_system | 0.79625596 |
| 97 | MP0001348_abnormal_lacrimal_gland | 0.76974932 |
| 98 | MP0005083_abnormal_biliary_tract | 0.76443984 |
| 99 | MP0008874_decreased_physiological_sensi | 0.75832822 |
| 100 | MP0005647_abnormal_sex_gland | 0.75611224 |
| 101 | MP0002933_joint_inflammation | 0.75004757 |
| 102 | MP0000465_gastrointestinal_hemorrhage | 0.74534181 |
| 103 | MP0001501_abnormal_sleep_pattern | 0.73502255 |
| 104 | MP0002136_abnormal_kidney_physiology | 0.73186185 |
| 105 | MP0008004_abnormal_stomach_pH | 0.70274953 |
| 106 | MP0003795_abnormal_bone_structure | 0.69601742 |
| 107 | MP0000703_abnormal_thymus_morphology | 0.68498525 |
| 108 | MP0008260_abnormal_autophagy | 0.67548349 |
| 109 | MP0003183_abnormal_peptide_metabolism | 0.63740623 |
| 110 | MP0005257_abnormal_intraocular_pressure | 0.63721020 |
| 111 | MP0000371_diluted_coat_color | 0.62984068 |
| 112 | MP0003279_aneurysm | 0.62813213 |
| 113 | MP0005595_abnormal_vascular_smooth | 0.61998875 |
| 114 | MP0001346_abnormal_lacrimal_gland | 0.61707259 |
| 115 | MP0002133_abnormal_respiratory_system | 0.60959438 |
| 116 | MP0005388_respiratory_system_phenotype | 0.60959438 |
| 117 | MP0003646_muscle_fatigue | 0.59773645 |
| 118 | MP0000627_abnormal_mammary_gland | 0.59339097 |
| 119 | MP0000609_abnormal_liver_physiology | 0.59227015 |
| 120 | MP0000490_abnormal_crypts_of | 0.59013516 |
| 121 | MP0004858_abnormal_nervous_system | 0.58785402 |
| 122 | MP0002332_abnormal_exercise_endurance | 0.58591075 |
| 123 | MP0002295_abnormal_pulmonary_circulatio | 0.58182384 |
| 124 | MP0001881_abnormal_mammary_gland | 0.57997535 |
| 125 | MP0005535_abnormal_body_temperature | 0.55821786 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 5.87214786 |
| 2 | Recurrent abscess formation (HP:0002722) | 5.77507442 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 5.28969610 |
| 4 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.26125002 |
| 5 | Interstitial pulmonary disease (HP:0006530) | 4.87586857 |
| 6 | Myositis (HP:0100614) | 4.68060707 |
| 7 | Orchitis (HP:0100796) | 4.60527536 |
| 8 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.54942572 |
| 9 | Abnormality of macrophages (HP:0004311) | 4.53828108 |
| 10 | Mediastinal lymphadenopathy (HP:0100721) | 4.44508408 |
| 11 | Hematochezia (HP:0002573) | 4.44128089 |
| 12 | Retrobulbar optic neuritis (HP:0100654) | 4.35177462 |
| 13 | Optic neuritis (HP:0100653) | 4.35177462 |
| 14 | Disinhibition (HP:0000734) | 4.17758148 |
| 15 | Stomatitis (HP:0010280) | 4.01978433 |
| 16 | Nuclear cataract (HP:0100018) | 3.73497709 |
| 17 | Autoimmune thrombocytopenia (HP:0001973) | 3.69527126 |
| 18 | Chronic otitis media (HP:0000389) | 3.65748636 |
| 19 | Recurrent fungal infections (HP:0002841) | 3.62326137 |
| 20 | Abnormality of the nasal mucosa (HP:0000433) | 3.60103305 |
| 21 | Vasculitis (HP:0002633) | 3.57087656 |
| 22 | Recurrent skin infections (HP:0001581) | 3.51243901 |
| 23 | Neurofibrillary tangles (HP:0002185) | 3.49105543 |
| 24 | Mutism (HP:0002300) | 3.47907917 |
| 25 | Thick nail (HP:0001805) | 3.35504176 |
| 26 | Pustule (HP:0200039) | 3.32087304 |
| 27 | Colitis (HP:0002583) | 3.31250863 |
| 28 | Gingivitis (HP:0000230) | 3.28620538 |
| 29 | Pulmonary infiltrates (HP:0002113) | 3.24456359 |
| 30 | Increased cerebral lipofuscin (HP:0011813) | 3.23243581 |
| 31 | Increased IgM level (HP:0003496) | 3.21424866 |
| 32 | Tetraparesis (HP:0002273) | 3.17194317 |
| 33 | Vacuolated lymphocytes (HP:0001922) | 3.12117765 |
| 34 | Recurrent viral infections (HP:0004429) | 3.12100200 |
| 35 | Systemic lupus erythematosus (HP:0002725) | 3.09113101 |
| 36 | Spontaneous hematomas (HP:0007420) | 3.01415624 |
| 37 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.98183025 |
| 38 | Complement deficiency (HP:0004431) | 2.96298946 |
| 39 | Keratoconjunctivitis (HP:0001096) | 2.95314724 |
| 40 | Nasal polyposis (HP:0100582) | 2.91049363 |
| 41 | Arterial thrombosis (HP:0004420) | 2.89934935 |
| 42 | Apathy (HP:0000741) | 2.89895696 |
| 43 | Recurrent cutaneous fungal infections (HP:0011370) | 2.87952617 |
| 44 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.87952617 |
| 45 | Esophageal varix (HP:0002040) | 2.85764389 |
| 46 | Increased serum ferritin (HP:0003281) | 2.79995087 |
| 47 | Basal ganglia calcification (HP:0002135) | 2.77979983 |
| 48 | Diminished motivation (HP:0000745) | 2.77604151 |
| 49 | Periodontitis (HP:0000704) | 2.76810092 |
| 50 | Hemoptysis (HP:0002105) | 2.73170348 |
| 51 | Keratoconjunctivitis sicca (HP:0001097) | 2.72546539 |
| 52 | Leukocytosis (HP:0001974) | 2.67316594 |
| 53 | Prostate neoplasm (HP:0100787) | 2.65973494 |
| 54 | Inflammation of the large intestine (HP:0002037) | 2.61374771 |
| 55 | Gangrene (HP:0100758) | 2.60596812 |
| 56 | Cellulitis (HP:0100658) | 2.59338776 |
| 57 | Purpura (HP:0000979) | 2.56720762 |
| 58 | Cerebral inclusion bodies (HP:0100314) | 2.55443601 |
| 59 | Amyloidosis (HP:0011034) | 2.54620865 |
| 60 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.52442256 |
| 61 | Polycythemia (HP:0001901) | 2.52200429 |
| 62 | Abnormality of complement system (HP:0005339) | 2.51617455 |
| 63 | Progressive neurologic deterioration (HP:0002344) | 2.50370782 |
| 64 | Hypergammaglobulinemia (HP:0010702) | 2.48685351 |
| 65 | Chronic obstructive pulmonary disease (HP:0006510) | 2.47374829 |
| 66 | Obstructive lung disease (HP:0006536) | 2.47374829 |
| 67 | Urticaria (HP:0001025) | 2.46103923 |
| 68 | Gastrointestinal infarctions (HP:0005244) | 2.45639459 |
| 69 | Parakeratosis (HP:0001036) | 2.44522259 |
| 70 | Gastrointestinal inflammation (HP:0004386) | 2.43180467 |
| 71 | Myocardial infarction (HP:0001658) | 2.41850329 |
| 72 | Neuronal loss in central nervous system (HP:0002529) | 2.39530426 |
| 73 | Osteomyelitis (HP:0002754) | 2.38068349 |
| 74 | Premature loss of primary teeth (HP:0006323) | 2.36833609 |
| 75 | Axonal loss (HP:0003447) | 2.36509726 |
| 76 | Porencephaly (HP:0002132) | 2.34996467 |
| 77 | Osteolytic defects of the hand bones (HP:0009699) | 2.33790158 |
| 78 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.33790158 |
| 79 | Recurrent bronchitis (HP:0002837) | 2.33276848 |
| 80 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.31008358 |
| 81 | Inappropriate behavior (HP:0000719) | 2.24791601 |
| 82 | Gingival bleeding (HP:0000225) | 2.24451077 |
| 83 | Metaphyseal irregularity (HP:0003025) | 2.23689481 |
| 84 | Meningitis (HP:0001287) | 2.23552633 |
| 85 | Loss of speech (HP:0002371) | 2.16865200 |
| 86 | Emphysema (HP:0002097) | 2.16727473 |
| 87 | Abnormality of iron homeostasis (HP:0011031) | 2.13383327 |
| 88 | Eosinophilia (HP:0001880) | 2.12468689 |
| 89 | Nausea (HP:0002018) | 2.12009881 |
| 90 | Increased IgE level (HP:0003212) | 2.11251126 |
| 91 | Glomerulonephritis (HP:0000099) | 2.09920403 |
| 92 | Prolonged neonatal jaundice (HP:0006579) | 2.09273966 |
| 93 | Dysostosis multiplex (HP:0000943) | 2.09229332 |
| 94 | Vertebral compression fractures (HP:0002953) | 2.08887668 |
| 95 | Skin ulcer (HP:0200042) | 2.07755065 |
| 96 | Hepatosplenomegaly (HP:0001433) | 2.06719331 |
| 97 | Abnormality of the pleura (HP:0002103) | 2.02135325 |
| 98 | Upper motor neuron abnormality (HP:0002127) | 2.01837959 |
| 99 | Conjunctival telangiectasia (HP:0000524) | 2.01555782 |
| 100 | Autoimmune hemolytic anemia (HP:0001890) | 2.01266816 |
| 101 | Personality changes (HP:0000751) | 2.00652493 |
| 102 | Asymmetric septal hypertrophy (HP:0001670) | 1.99274435 |
| 103 | Anorexia (HP:0002039) | 1.98966897 |
| 104 | Agnosia (HP:0010524) | 1.97102423 |
| 105 | Petechiae (HP:0000967) | 1.95576369 |
| 106 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.94476587 |
| 107 | Mucopolysacchariduria (HP:0008155) | 1.94476587 |
| 108 | Nephritis (HP:0000123) | 1.94066411 |
| 109 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.93001693 |
| 110 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.93001693 |
| 111 | Abnormality of glycolipid metabolism (HP:0010969) | 1.93001693 |
| 112 | Pulmonary embolism (HP:0002204) | 1.92778266 |
| 113 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.92591652 |
| 114 | Recurrent pneumonia (HP:0006532) | 1.92385906 |
| 115 | Polyneuropathy (HP:0001271) | 1.91030434 |
| 116 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.90687506 |
| 117 | Thrombocytosis (HP:0001894) | 1.89805070 |
| 118 | Bone pain (HP:0002653) | 1.89572175 |
| 119 | Arthralgia (HP:0002829) | 1.89567710 |
| 120 | Acne (HP:0001061) | 1.89303090 |
| 121 | Joint swelling (HP:0001386) | 1.88934039 |
| 122 | Dementia (HP:0000726) | 1.88805567 |
| 123 | Gastrointestinal stroma tumor (HP:0100723) | 1.88740797 |
| 124 | Memory impairment (HP:0002354) | 1.88373846 |
| 125 | Abnormality of the pericardium (HP:0001697) | 1.87556609 |
| 126 | Stomach cancer (HP:0012126) | 1.87445222 |
| 127 | Malnutrition (HP:0004395) | 1.87102230 |
| 128 | Restrictive lung disease (HP:0002091) | 1.86408149 |
| 129 | Encephalitis (HP:0002383) | 1.85828836 |
| 130 | Epistaxis (HP:0000421) | 1.85802950 |
| 131 | Chronic sinusitis (HP:0011109) | 1.85518402 |
| 132 | Glomerulopathy (HP:0100820) | 1.84110625 |
| 133 | IgA deficiency (HP:0002720) | 1.83947262 |
| 134 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.83452746 |
| 135 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.83452746 |
| 136 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.83452746 |
| 137 | Hydroxyprolinuria (HP:0003080) | 1.83231494 |
| 138 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.82464722 |
| 139 | Peripheral demyelination (HP:0011096) | 1.82260853 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K14 | 5.34618402 |
| 2 | TBK1 | 4.02279732 |
| 3 | TYK2 | 3.42372922 |
| 4 | IKBKE | 3.27166973 |
| 5 | IRAK3 | 3.16533979 |
| 6 | TAOK2 | 3.13905971 |
| 7 | DDR2 | 2.98700502 |
| 8 | IKBKB | 2.84846874 |
| 9 | JAK3 | 2.66950783 |
| 10 | TGFBR2 | 2.54532112 |
| 11 | RIPK4 | 2.50221256 |
| 12 | IRAK4 | 2.46091480 |
| 13 | MAP4K1 | 2.27652200 |
| 14 | PRPF4B | 2.23684403 |
| 15 | CHUK | 2.18070477 |
| 16 | JAK1 | 2.16775729 |
| 17 | TAOK1 | 2.08210248 |
| 18 | ERN1 | 2.00614018 |
| 19 | EPHB1 | 1.97802890 |
| 20 | KIT | 1.96011437 |
| 21 | BLK | 1.95309669 |
| 22 | PIM2 | 1.89718190 |
| 23 | MAP3K13 | 1.80340479 |
| 24 | TIE1 | 1.79956106 |
| 25 | TXK | 1.74025061 |
| 26 | FGFR4 | 1.60429121 |
| 27 | CDC42BPA | 1.58237568 |
| 28 | CSK | 1.56332347 |
| 29 | RIPK1 | 1.48159633 |
| 30 | ZAP70 | 1.43191905 |
| 31 | MAP3K3 | 1.37996938 |
| 32 | RPS6KA4 | 1.33551324 |
| 33 | KDR | 1.31198146 |
| 34 | STK10 | 1.30343828 |
| 35 | EPHA3 | 1.28170555 |
| 36 | MST4 | 1.24672187 |
| 37 | PIM1 | 1.21966059 |
| 38 | ADRBK2 | 1.17932852 |
| 39 | FGFR3 | 1.17813227 |
| 40 | TGFBR1 | 1.08951742 |
| 41 | JAK2 | 1.08519931 |
| 42 | HCK | 1.07966430 |
| 43 | IRAK2 | 1.07177091 |
| 44 | MATK | 1.04651753 |
| 45 | PTK6 | 1.03871055 |
| 46 | CSF1R | 1.01446131 |
| 47 | LATS2 | 0.98884557 |
| 48 | LCK | 0.97782225 |
| 49 | MAP2K3 | 0.97661781 |
| 50 | MARK3 | 0.96791371 |
| 51 | BTK | 0.95452059 |
| 52 | SYK | 0.94399550 |
| 53 | EIF2AK2 | 0.93483353 |
| 54 | BMX | 0.92101524 |
| 55 | FGR | 0.90496120 |
| 56 | NEK9 | 0.89409313 |
| 57 | LRRK2 | 0.89341205 |
| 58 | PDGFRA | 0.84549267 |
| 59 | TEC | 0.84545172 |
| 60 | TAOK3 | 0.82545549 |
| 61 | PBK | 0.77896891 |
| 62 | CDK12 | 0.77001273 |
| 63 | ARAF | 0.76047101 |
| 64 | MAP3K10 | 0.75965731 |
| 65 | TYRO3 | 0.75750212 |
| 66 | ITK | 0.75191825 |
| 67 | PAK4 | 0.74715239 |
| 68 | LYN | 0.74550980 |
| 69 | EGFR | 0.73678026 |
| 70 | EPHA2 | 0.73609711 |
| 71 | TESK1 | 0.64685459 |
| 72 | NLK | 0.64466037 |
| 73 | ABL1 | 0.64131900 |
| 74 | MAP3K11 | 0.62213160 |
| 75 | TESK2 | 0.60843886 |
| 76 | TTN | 0.60391325 |
| 77 | BMPR2 | 0.60343637 |
| 78 | ICK | 0.60319800 |
| 79 | SIK3 | 0.59138702 |
| 80 | FES | 0.58038654 |
| 81 | CDK6 | 0.57937409 |
| 82 | IRAK1 | 0.57857755 |
| 83 | ACVR1B | 0.57439654 |
| 84 | NME2 | 0.56716304 |
| 85 | HIPK2 | 0.54974419 |
| 86 | PDGFRB | 0.54828902 |
| 87 | MAP3K5 | 0.52696201 |
| 88 | MAPK4 | 0.52674017 |
| 89 | GSK3A | 0.52564317 |
| 90 | PRKCD | 0.52000674 |
| 91 | ABL2 | 0.51550252 |
| 92 | MAP2K6 | 0.49855329 |
| 93 | MAPKAPK2 | 0.49756212 |
| 94 | STK3 | 0.49115250 |
| 95 | STK4 | 0.45796877 |
| 96 | CLK1 | 0.42592371 |
| 97 | SIK2 | 0.41835641 |
| 98 | SIK1 | 0.41154390 |
| 99 | PKN1 | 0.40733842 |
| 100 | DAPK3 | 0.39372606 |
| 101 | PRKG2 | 0.37852113 |
| 102 | MAP3K1 | 0.37288032 |
| 103 | MOS | 0.36181016 |
| 104 | MAPK7 | 0.35571775 |
| 105 | DYRK3 | 0.35564504 |
| 106 | MST1R | 0.33605267 |
| 107 | PDPK1 | 0.30223283 |
| 108 | DYRK1B | 0.29249745 |
| 109 | RPS6KC1 | 0.28982061 |
| 110 | RPS6KL1 | 0.28982061 |
| 111 | STK24 | 0.28775620 |
| 112 | RPS6KA6 | 0.28770156 |
| 113 | DAPK2 | 0.28291363 |
| 114 | GRK7 | 0.28249658 |
| 115 | INSR | 0.27331534 |
| 116 | MAPK15 | 0.27306895 |
| 117 | TRIB3 | 0.26247943 |
| 118 | PRKCQ | 0.25719929 |
| 119 | NUAK1 | 0.25638768 |
| 120 | RPS6KA5 | 0.25564867 |
| 121 | TRPM7 | 0.25518023 |
| 122 | PDK1 | 0.25458324 |
| 123 | PTK2B | 0.24829306 |
| 124 | MAP2K2 | 0.24476546 |
| 125 | CAMK1D | 0.23735710 |
| 126 | IGF1R | 0.23313090 |
| 127 | MAP3K8 | 0.22311664 |
| 128 | GRK6 | 0.22175474 |
| 129 | RPS6KA2 | 0.20086396 |
| 130 | CAMKK2 | 0.18821423 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 3.27929958 |
| 2 | * NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.92194796 |
| 3 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.73731680 |
| 4 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.70795031 |
| 5 | Allograft rejection_Homo sapiens_hsa05330 | 2.69633476 |
| 6 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.58324098 |
| 7 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.46579244 |
| 8 | Legionellosis_Homo sapiens_hsa05134 | 2.38714407 |
| 9 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.34209706 |
| 10 | * Malaria_Homo sapiens_hsa05144 | 2.32181383 |
| 11 | Pertussis_Homo sapiens_hsa05133 | 2.29776840 |
| 12 | * TNF signaling pathway_Homo sapiens_hsa04668 | 2.27317820 |
| 13 | Measles_Homo sapiens_hsa05162 | 2.21805259 |
| 14 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.16057560 |
| 15 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.11531081 |
| 16 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.98024122 |
| 17 | * Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.88501401 |
| 18 | * Influenza A_Homo sapiens_hsa05164 | 1.88488329 |
| 19 | Tuberculosis_Homo sapiens_hsa05152 | 1.88460974 |
| 20 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.82474257 |
| 21 | Asthma_Homo sapiens_hsa05310 | 1.80147601 |
| 22 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.76821741 |
| 23 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.74645380 |
| 24 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.67764589 |
| 25 | Apoptosis_Homo sapiens_hsa04210 | 1.67086176 |
| 26 | * Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.62818839 |
| 27 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.54764673 |
| 28 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.53559703 |
| 29 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.50834176 |
| 30 | * African trypanosomiasis_Homo sapiens_hsa05143 | 1.50202088 |
| 31 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.50074307 |
| 32 | Shigellosis_Homo sapiens_hsa05131 | 1.48042515 |
| 33 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.42957027 |
| 34 | Salmonella infection_Homo sapiens_hsa05132 | 1.38734656 |
| 35 | Hepatitis C_Homo sapiens_hsa05160 | 1.35433783 |
| 36 | Lysosome_Homo sapiens_hsa04142 | 1.31368712 |
| 37 | * AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.30323828 |
| 38 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.26005458 |
| 39 | Phagosome_Homo sapiens_hsa04145 | 1.25536621 |
| 40 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.25043721 |
| 41 | Hepatitis B_Homo sapiens_hsa05161 | 1.22180381 |
| 42 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.17304363 |
| 43 | * Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.13920916 |
| 44 | Bladder cancer_Homo sapiens_hsa05219 | 1.13809107 |
| 45 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.12677086 |
| 46 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.12542407 |
| 47 | Amoebiasis_Homo sapiens_hsa05146 | 1.12253274 |
| 48 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.07369760 |
| 49 | * Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.04438178 |
| 50 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.01984476 |
| 51 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.96882918 |
| 52 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.91963511 |
| 53 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.91948822 |
| 54 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.86577356 |
| 55 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.86323741 |
| 56 | * Viral myocarditis_Homo sapiens_hsa05416 | 0.85599343 |
| 57 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.85284363 |
| 58 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.84684672 |
| 59 | Other glycan degradation_Homo sapiens_hsa00511 | 0.83156884 |
| 60 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.81763738 |
| 61 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.76206471 |
| 62 | * Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.72934702 |
| 63 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.69703805 |
| 64 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.68872718 |
| 65 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.67080903 |
| 66 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.61524956 |
| 67 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.61504296 |
| 68 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.61127004 |
| 69 | Platelet activation_Homo sapiens_hsa04611 | 0.60884098 |
| 70 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.60191927 |
| 71 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.59662432 |
| 72 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.58594786 |
| 73 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.58055340 |
| 74 | * HTLV-I infection_Homo sapiens_hsa05166 | 0.55689275 |
| 75 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.54968169 |
| 76 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.52799774 |
| 77 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.52520545 |
| 78 | Adherens junction_Homo sapiens_hsa04520 | 0.52030687 |
| 79 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.50864032 |
| 80 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.50739724 |
| 81 | Insulin resistance_Homo sapiens_hsa04931 | 0.50656573 |
| 82 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.49600277 |
| 83 | Prion diseases_Homo sapiens_hsa05020 | 0.49404522 |
| 84 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.49316454 |
| 85 | Focal adhesion_Homo sapiens_hsa04510 | 0.48842182 |
| 86 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.48450423 |
| 87 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.46378942 |
| 88 | Galactose metabolism_Homo sapiens_hsa00052 | 0.45211258 |
| 89 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.44982162 |
| 90 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.44837793 |
| 91 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.44504181 |
| 92 | * Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.44217935 |
| 93 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.43321634 |
| 94 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.41095755 |
| 95 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.38819865 |
| 96 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.37103820 |
| 97 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.36795675 |
| 98 | Prostate cancer_Homo sapiens_hsa05215 | 0.36775752 |
| 99 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.33978218 |
| 100 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.33899632 |
| 101 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.33778601 |
| 102 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.31743600 |
| 103 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.31197975 |
| 104 | Pathways in cancer_Homo sapiens_hsa05200 | 0.29949991 |
| 105 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.29911813 |
| 106 | Endocytosis_Homo sapiens_hsa04144 | 0.28974190 |
| 107 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.27838385 |
| 108 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.24030534 |
| 109 | Mineral absorption_Homo sapiens_hsa04978 | 0.23116753 |
| 110 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.21799745 |
| 111 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.19136023 |
| 112 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.17304398 |
| 113 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.15291765 |
| 114 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.14357727 |
| 115 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.12094410 |

